As of July 14, 2026, Centessa Pharmaceuticals plc (CNTA) has a DilutionWatch DilutionScore of 28/100, rated MEDIUM dilution risk. Centessa Pharmaceuticals plc has a market capitalization of $6.15B, 154.73M shares outstanding, 162 institutional holders tracked. Key dilution vectors include approximately 16 months of cash runway.
Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.
📊 Score Breakdown
🔄Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CNTA.
💹 Market Data
Market Cap$6.15B
Shares Outstanding154.73M
Float92.48M
Cash$276.59M
Debt$116.07M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 18.6% shares (2026Q1 vs prior)
162 institutional holders · 177.48M shares
#1
Avoro Capital Advisors LLC
25.99M shares
#2
Medicxi Ventures Management (Jersey) Ltd
19.96M shares
#3
PERCEPTIVE ADVISORS LLC
10.52M shares
📉 Short Interest
Short Interest1.61M
Days to Cover1.2
% of Float1.7%
FINRA data as of Jun 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2022
Form 4
INSIDER TRANSACTION
Mar 26, 2026
Form 4
INSIDER TRANSACTION
Mar 26, 2026
Form 4
INSIDER TRANSACTION
Mar 17, 2026
Form 4
INSIDER TRANSACTION
Mar 13, 2026
Full SEC filing analysis available with free account
→
📰 Recent News
No recent news
📋 What This Means for CNTA Shareholders
Centessa Pharmaceuticals plc (CNTA) has a DilutionScore of 28/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.
Cash runway is a key watch item: CNTA has approximately 16 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.
DilutionWatch tracks over 25 SEC filing types for CNTA in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CNTA alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.
Track CNTA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CNTA — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
🔬 More Research for CNTA
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.